跳至主要内容
临床试验/IRCT20201019049075N2
IRCT20201019049075N2已完成3 期

Randomized Placebo-controlled trial of the effect of intranasal administration of desmopressin acetate on the bleeding complications after renal needle-biopsy sampling in patients with normal renal function

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 no limit(—)
性别
All

入选标准

  • Patients referred for renal biopsy.

排除标准

  • Blood pressure more than 160/90 mmhg,
  • Abnormal kidney function (serum creatinine more than 1.5 mg/dl and GFR less than 60 cc/min by CKD-EPI formula),
  • Serum sodium less than 130 meq/liter,
  • Taking anti-platelets or anticoagulants
  • Thrombocytopenia
  • History of kidney cancer
  • Solitary kidney
  • Small size kidneys
  • Active urinary tract infection
  • Abnormal prothrombin time

研究者

相似试验